An FDA advisory panel is expected to meet on Thursday to discuss Moderna's COVID-19 booster shot, and will go through the whole process against for the Johnson & Johnson vaccine.
An FDA advisory panel is expected to meet on Thursday to discuss Moderna's COVID-19 booster shot, and will go through the whole process against for the Johnson & Johnson vaccine.
If given final approval, children ages 5 to 11 could be given two lower doses of the Pfizer vaccine spaced out three weeks apart.
The FDA is expected to approve booster shots for both the Moderna and Pfizer COVID-19 vaccines Wednesday. The FDA is also expected..